SCHEMBL4640935

SCHEMBL4640935

CNC(=O)CC[CH]CCO

nearest known ligand 0.43

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.43
CNR1 P21554 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MCL1 Q07820 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL146293 0.75
SCHEMBL82068 0.73
SCHEMBL25933296 0.73
SCHEMBL2879345 0.73 TSHR (0.52) LMNAALDH1A1POLB
SCHEMBL442562 0.71
SCHEMBL28340352 0.71
SCHEMBL19300404 0.71
SCHEMBL3660629 0.71 LMNA (0.63) LMNAALDH1A1MCL1POLB
SCHEMBL775285 0.70
SCHEMBL8015405 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1869032-B1 PYRIMIDINE DERIVATIVES FOR USE AS ANTICANCER AGENTS ASTRAZENECA AB (SE) 2008-08-13 EP disclosed